Gut Microbial Diversity in Women With Polycystic Ovary Syndrome Correlates With Hyperandrogenism
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Context: A majority of women with polycystic ovary syndrome (PCOS) have metabolic abnormalities that result in an increased risk of developing type 2 diabetes and heart disease. Correlative studies have shown an association between changes in the gut microbiome and metabolic disorders. Two recent studies reported a decrease in α diversity of the gut microbiome in women with PCOS compared with healthy women. Objective: We investigated whether changes in the gut microbiome correlated with specific clinical parameters in women with PCOS compared with healthy women. We also investigated whether there were changes in the gut microbiome in women with polycystic ovarian morphology (PCOM) who lacked the other diagnostic criteria of PCOS. Participants: Subjects were recruited at the Poznan University of Medical Sciences. Fecal microbial diversity profiles of healthy women (n = 48), women with PCOM (n = 42), and women diagnosed with PCOS using the Rotterdam criteria (n = 73) were analyzed using 16S ribosomal RNA gene sequencing. Results: Lower α diversity was observed in women with PCOS compared with healthy women. Women with PCOM had a change in α diversity that was intermediate between that of the other two groups. Regression analyses showed that hyperandrogenism, total testosterone, and hirsutism were negatively correlated with α diversity. Permutational multivariate analysis of variance in UniFrac distances showed that hyperandrogenism was also correlated with β diversity. A random forest identified bacteria that discriminated between healthy women and women with PCOS. Conclusion: These results suggest that hyperandrogenism may play a critical role in altering the gut microbiome in women with PCOS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In keeping with the developmental origins hypothesis previously discussed, maternal androgens may alter the composition and function of the microbiome, therefore facilitating the pathogenesis of PCOS [140].”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [140]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although most studies are small, dysbiosis has consistently been found to correlate with different physiological parameters, such as obesity, sex hormones and metabolic defects [140,141,143].”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [140]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“One study showed that beta diversity, which is used to measure differences between groups, was negatively correlated with hyperandrogenism, suggesting that androgens play a significant role in dysbiosis [140].”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [140]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Decreased α-diversity has been described in women with PCOS [109, 110].”
From Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls (2019) · cites this paper as [110]
The cited source says what the claim attributes to it.
In the citing paper
“Dysbiosis is a consistent finding when looking at the microbiome of women with PCOS [140,141,142,143].”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [140]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
A Mathematical Theory of Communication
Shannon, C. E. (1948) · Bell System Technical Journal · doi:10.1002/j.1538-7305.1948.tb01338.x · Cited by 88,486
A Mathematical Theory of Communication
Shannon, C. E. (1948) · Bell System Technical Journal · doi:10.1002/j.1538-7305.1948.tb00917.x · Cited by 48,949
MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability
Katoh, K., & Standley, D. M. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst010 · Cited by 46,209 · cited 1×
“The resulting SVs were then aligned using MAFFT (21), and a phylogenetic tree was built using FastTree (22).”
MethodDADA2: High–resolution sample inference from Illumina amplicon data
Callahan, B. J., McMurdie, P. J., Rosen, M. J., Han, A. W., Johnson, A. J. A., & Holmes, S. P. (2016) · Nature Methods · doi:10.1038/nmeth.3869 · Cited by 35,698 · cited 1×
“DADA2 software was used to obtain a set of observed sequence variants (SVs) (19).”
MethodQIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887 · cited 1×
“6/) (18) using the q2-tools-import script, and sequences were demultiplexed using the q2-demux emp-single script.”
MethodSelf-citationAn obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 1×
“Fecal microbiome transplantation from obese humans into germ-free mice also resulted in an obese phenotype, indicating a potential causative role of the gut microbiome in the development of metabolic disorders (13, 14).”
BackgroundUltra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms
Caporaso, J. G., Lauber, C. L., Walters, W. A., Berg-Lyons, D., Huntley, J., Fierer, N., Owens, S. M., Betley, J., Fraser, L., Bauer, M., et al. (2012) · The ISME Journal · doi:10.1038/ismej.2012.8 · Cited by 8,839 · cited 1×
“For each sample, the V4 hypervariable region of the 16S ribosomal RNA (rRNA) gene was polymerase chain reaction (PCR) amplified with primers 515F and 806R (16).”
MethodHuman gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
UniFrac: a New Phylogenetic Method for Comparing Microbial Communities
Lozupone, C., & Knight, R. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.12.8228-8235.2005 · Cited by 8,227
Cited by
Gut microbiota–bile acid–interleukin-22 axis orchestrates polycystic ovary syndrome
Qi, X., Yun, C., Sun, L., Xia, J., Wu, Q., Wang, Y., Wang, L., Zhang, Y., Liang, X., Wang, L., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0509-0 · Cited by 846
Witchel, S. F., Oberfield, S. E., & Peña, A. S. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00078 · Cited by 653
“Decreased a-diversity has been described in women with PCOS [109, 110].”
BackgroundGut microbiome and its role in obesity and insulin resistance
Lee, C. J., Sears, C. L., & Maruthur, N. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14107 · Cited by 350
Lifestyle management in polycystic ovary syndrome – beyond diet and physical activity
Cowan, S., Lim, S., Alycia, C., Pirotta, S., Thomson, R., Gibson-Helm, M., Blackmore, R., Naderpoor, N., Bennett, C., Ee, C., et al. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01208-y · Cited by 240
“These findings may be linked to lower microbial diversity and increased intestinal permeability in women with PCOS [230, 231].”
BackgroundRoles of Sex Hormones and Gender in the Gut Microbiota
Yoon, K., & Kim, N. (2021) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm20208 · Cited by 299
Gut microbiota and the polycystic ovary syndrome: influence of sex, sex hormones, and obesity
Insenser, M., Murri, M., del Campo, R., Martínez-García, M. Á., Fernández-Durán, E., & Escobar-Morreale, H. F. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02799 · Cited by 312
Zhang, J., Sun, Z., Jiang, S., Bai, X., Ma, C., Peng, Q., Chen, K., Chang, H., Fang, T., & Zhang, H. (2019) · mSystems · doi:10.1128/msystems.00017-19 · Cited by 282
“These studies involved women from Europe and China diagnosed with PCOS (25, 26).”
BackgroundHe, F.-F., & Li, Y.-M. (2020) · Journal of Ovarian Research · doi:10.1186/s13048-020-00670-3 · Cited by 289
“Several studies have reported a decrease in α diversity and a change in β diversity in patients with PCOS [18, 20].”
BackgroundMetabolic Syndrome and PCOS: Pathogenesis and the Role of Metabolites
Chen, W., & Pang, Y. (2021) · Metabolites · doi:10.3390/metabo11120869 · Cited by 228
Sex, microbes, and polycystic ovary syndrome
Thackray, V. G. (2019) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.11.001 · Cited by 203
“showed that a decrease in alpha diversity was negatively correlated with total testosterone levels and hirsutism [51].”
BackgroundSelf-citationMolina, N., Sola-Leyva, A., Saez-Lara, M., Plaza-Diaz, J., Tubić-Pavlović, A., Romero, B., Clavero, A., Mozas-Moreno, J., Fontes, J., & Altmäe, S. (2020) · Biomolecules · doi:10.3390/biom10040593 · Cited by 187
Zeng, B., Lai, Z., Sun, L., Zhang, Z., Yang, J., Li, Z., Lin, J., & Zhang, Z. (2019) · Research in Microbiology · doi:10.1016/j.resmic.2018.09.002 · Cited by 188
Nutritional Supplements and Complementary Therapies in Polycystic Ovary Syndrome
Alesi, S., Ee, C., Moran, L. J., Rao, V., & Mousa, A. (2022) · Advances in Nutrition · doi:10.1093/advances/nmab141 · Cited by 146
Jobira, B., Frank, D. N., Pyle, L., Silveira, L. J., Kelsey, M. M., Garcia-Reyes, Y., Robertson, C. E., Ir, D., Nadeau, K. J., & Cree-Green, M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz263 · Cited by 162
Chen, Y., Yang, B., Ross, R. P., Jin, Y., Stanton, C., Zhao, J., Zhang, H., & Chen, W. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b05744 · Cited by 185
Polycystic ovarian syndrome-current pharmacotherapy and clinical implications
Rashid, R., Mir, S. A., Kareem, O., Ali, T., Ara, R., Malik, A., Amin, F., & Bader, G. N. (2022) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2021.11.009 · Cited by 156
Microbiome and PCOS: State-of-Art and Future Aspects
Giampaolino, P., Foreste, V., Di Filippo, C., Gallo, A., Mercorio, A., Serafino, P., Improda, F. P., Verrazzo, P., Zara, G., Buonfantino, C., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042048 · Cited by 163
“Several studies have reported a change in α and β diversity in patients with PCOS [25,26,30,31].”
BackgroundResultInfluentialThe latest reports and treatment methods on polycystic ovary syndrome
Stańczak, N. A., Grywalska, E., & Dudzińska, E. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2357737 · Cited by 194
“Similar outcomes were reported in studies supplementing women with PCOS with L. casei , L. acidophilus , L. rhamnosus , L. bulgaricus , B. breve , B. longum and Streptococcus thermophiles for 8 weeks, which resulted in notable reductions in serum glucose and insulin levels [77].”
ResultA New Approach to Polycystic Ovary Syndrome: The Gut Microbiota
Yurtdaş, G., & Akdevelioğlu, Y. (2020) · Journal of the American College of Nutrition · doi:10.1080/07315724.2019.1657515 · Cited by 153
“Several studies have reported that women with PCOS had decreased alpha (a) diversity and altered beta (b) diversity (8, 42, 43).”
BackgroundWang, T., Sha, L., Li, Y., Zhu, L., Wang, Z., Li, K., Lu, H., Bao, T., Guo, L., Zhang, X., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00284 · Cited by 162
“Dietary FO Restored Gut Dysbiosis in PCOS Emerging evidences have demonstrated that the gut microbiota is an essential element in the occurrence and the development of PCOS (23, 44).”
BackgroundHan, Q., Wang, J., Li, W., Chen, Z., & Du, Y. (2021) · Microbiome · doi:10.1186/s40168-021-01046-5 · Cited by 163
“Alterations in gut microbiota were often associated with hyperandrogenism and metabolic markers [16, 18].”
BackgroundDi Lorenzo, M., Cacciapuoti, N., Lonardo, M. S., Nasti, G., Gautiero, C., Belfiore, A., Guida, B., & Chiurazzi, M. (2023) · Current Nutrition Reports · doi:10.1007/s13668-023-00479-8 · Cited by 108
Systematic low-grade chronic inflammation and intrinsic mechanisms in polycystic ovary syndrome
Deng, H., Chen, Y., Xing, J., Zhang, N., & Xu, L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1470283 · Cited by 170
d’Afflitto, M., Upadhyaya, A., Green, A., & Peiris, M. (2022) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001676 · Cited by 142
Characteristic gut microbiota and predicted metabolic functions in women with PCOS
Zhou, L., Ni, Z., Cheng, W., Yu, J., Sun, S., Zhai, D., Yu, C., & Cai, Z. (2020) · Endocrine Connections · doi:10.1530/ec-19-0522 · Cited by 141
Female reproductive dysfunctions and the gut microbiota
Chadchan, S. B., Singh, V., & Kommagani, R. (2022) · Journal of Molecular Endocrinology · doi:10.1530/jme-21-0238 · Cited by 133
“Regression analysis showed that hyperandrogenism, total testosterone, and hirsutism were negatively correlated with alpha diversity (Torres et al. 2018).”
BackgroundExploring the role of gut microbiome in male reproduction
Wang, Y., & Xie, Z. (2022) · Andrology · doi:10.1111/andr.13143 · Cited by 135
Zhao, X., Jiang, Y., Xi, H., Chen, L., & Feng, X. (2020) · Geburtshilfe und Frauenheilkunde · doi:10.1055/a-1081-2036 · Cited by 124
“Moreover, researchers have confirmed that the richness and phytogenetic diversity of GM species in patients with PCOS is significantly reduced compared with that of control groups [40].”
Li, P., Shuai, P., Shen, S., Zheng, H., Sun, P., Zhang, R., Lan, S., Lan, Z., Jayawardana, T. C., Yang, Y., et al. (2023) · BMC Medicine · doi:10.1186/s12916-023-02975-8 · Cited by 132
Chu, W., Han, Q., Xu, J., Wang, J., Sun, Y., Li, W., Chen, Z.-J., & Du, Y. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.01.027 · Cited by 121
The Gut Microbiome and Female Health
Siddiqui, R., Makhlouf, Z., Alharbi, A. M., Alfahemi, H. H., & Khan, N. A. (2022) · Biology · doi:10.3390/biology11111683 · Cited by 131
Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment
Parker, J., O’Brien, C., Hawrelak, J., & Gersh, F. L. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19031336 · Cited by 114
“As previously discussed, low diversity is one of the key microbiota patterns observed in women with PCOS, and has been positively associated with hyperandrogenism, total testosterone levels, and hirsutism in this population (267).”
BackgroundPolycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment
parker, J., O'Brien, C., Hawrelak, J., & Gersh, F. (2021) · doi:10.20944/preprints202112.0088.v1 · Cited by 113
Obesity, Dietary Patterns, and Hormonal Balance Modulation: Gender-Specific Impacts
Mazza, E., Troiano, E., Ferro, Y., Lisso, F., Tosi, M., Turco, E., Pujia, R., & Montalcini, T. (2024) · Nutrients · doi:10.3390/nu16111629 · Cited by 128
“Several Several studies have reported alterations in the overall composition of gut bacteria in women with PCOS, showing a decrease in both species’ diversity within a sample (alpha diversity) and similarity between samples (beta diversity) [100].”
BackgroundGut and Vaginal Microbiomes in PCOS: Implications for Women’s Health
Gu, Y., Zhou, G., Zhou, F., Li, Y. O., Wu, Q., He, H., Zhang, Y., Ma, C., Ding, J., & Hua, K. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.808508 · Cited by 123
“Pedro J Torres found that exposure to a healthy gut microbiome could protect against the reproductive and metabolic dysregulation in a PCOS mouse model, which suggests that healthy gut microbiome is associated with improving phenotype of PCOS (78).”
BackgroundHe, Y., Wang, Q., Xiu, L., Wang, G., Zhao, J., Zhang, H., & Chen, W. (2020) · Food & Function · doi:10.1039/c9fo02554e · Cited by 114
Gut microbiota-gonadal axis: the impact of gut microbiota on reproductive functions
Ashonibare, V. J., Akorede, B. A., Ashonibare, P. J., Akhigbe, T. M., & Akhigbe, R. E. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1346035 · Cited by 116
Torres, P. J., Ho, B., Arroyo, P., Sau, L., Chen, A., Kelley, S. T., & Thackray, V. G. (2019) · Endocrinology · doi:10.1210/en.2019-00050 · Cited by 120
Self-citationGut microbiota alterations reveal potential gut–brain axis changes in polycystic ovary syndrome
Liang, Z., Di, N., Li, L., & Yang, D. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01481-5 · Cited by 109
Zhang, F., Ma, T., Cui, P., Tamadon, A., He, S., Huo, C., Yierfulati, G., Xu, X., Hu, W., Li, X., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00175 · Cited by 106
Bruni, V., Capozzi, A., & Lello, S. (2021) · Reproductive Sciences · doi:10.1007/s43032-021-00515-4 · Cited by 114
Intersection of Polycystic Ovary Syndrome and the Gut Microbiome
Rizk, M. G., & Thackray, V. G. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa177 · Cited by 104
“Using 16S rRNA gene sequencing, multiple studies reported that beta diversity was altered in fecal samples obtained from women with PCOS compared with healthy women [19, 22, 28].”
BackgroundInfluentialSelf-citationChen, Y., Jin, Y. J., Stanton, C., Ross, R. P., Zhao, J., Zhang, H., Yang, B. K., & Chen, W. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02252-x · Cited by 106
Gut Microbiota in Patients with Polycystic Ovary Syndrome: a Systematic Review
Guo, J., Shao, J., Yang, Y., Niu, X., Liao, J., Zhao, Q. S., Wang, D., Li, S., & Hu, J. (2021) · Reproductive Sciences · doi:10.1007/s43032-020-00430-0 · Cited by 127
“Table 1 Characteristics of the observational studies included in the systematic review Study Year Country Type of specimen Definite of PCOS Study design Group Population Age Microbiome assessment method Qi 2019 China Fecal samples Rotterdam criteria Cohort PCOS 50 20–40 Whole-genome shotgun sequencing HC 43 20–40 Inse…”
BackgroundInfluentialShi, J., Xie, Q., Yue, Y., Chen, Q., Zhao, L., Evivie, S. E., Li, B., & Huo, G. (2021) · Food & Function · doi:10.1039/d1fo00317h · Cited by 100
López-Moreno, A., & Aguilera, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071461 · Cited by 97
Sex hormones influence the intestinal microbiota composition in mice
Wu, Y., Peng, X., Li, X., Li, D., Tan, Z., & Yu, R. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.964847 · Cited by 101
“Studies showed that abnormal androgen levels can lead to intestinal dysbacteria, including enzymes involved in androgen metabolism, which further interfere with androgen metabolism, and are associated with diseases such as polycystic ovary syndrome (Lindheim et al., 2017; Liu et al., 2017; Torres et al., 2018; Zeng et…”
BackgroundGut microbiota dysbiosis in polycystic ovary syndrome: association with obesity—a preliminary report
Liang, Y., Ming, Q., Liang, J., Zhang, Y., Zhang, H., & Shen, T. (2020) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2019-0413 · Cited by 95
Gut microbiota: a hidden player in polycystic ovary syndrome
Senthilkumar, H., & Arumugam, M. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06315-7 · Cited by 102
“According to reports, these mediators may help women with PCOS maintain psychological well-being and control gastrointestinal habits [20, 46].”
InfluentialGut and vaginal microbiomes on steroids: implications for women’s health
Graham, M. E., Herbert, W. G., Song, S., Raman, H. N., Zhu, J. E., Gonzalez, P. E., Walther-Antonio, M. R. S., & Tetel, M. J. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.04.014 · Cited by 99
“PCOS is also associated with decreased GM richness and a lower relative abundance of bacteria that produce short-chain fatty acids (SCFAs), including Roseburia and Odoribacter, as well as with increased markers of intestinal dysbiosis and permeability [32,33].”
BackgroundEmanuel, R. H. K., Roberts, J., Docherty, P. D., Lunt, H., Campbell, R. E., & Möller, K. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1017468 · Cited by 101
Li, L., Han, J., Wu, L., Fang, C., Li, W., Gu, J., Deng, T., Qin, C., Nie, J.-Y., & Zeng, X. (2022) · Military Medical Research · doi:10.1186/s40779-022-00373-4 · Cited by 95
“[55] have reported that total testosterone may play a vital role in variation of gut microbiota in women with polycystic ovary syndrome, another study has found that increased Parasutterella abundance was positively correlated with serum testosterone level [56], while Ruminococcaceae was reported to be negatively corr…”
BackgroundFemale reproductive tract-organ axes
Takada, K., Melnikov, V. G., Kobayashi, R., Komine‐Aizawa, S., Tsuji, N. M., & Hayakawa, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1110001 · Cited by 91
Mora, P. E., Valbuena, D., & Díez‐Juan, A. (2025) · Life · doi:10.3390/life15050762 · Cited by 96
The Gut Microbiome in Polycystic Ovary Syndrome and Its Association with Metabolic Traits
Lüll, K., Arffman, R. K., Sola‐Leyva, A., Molina, N. M., Aasmets, O., Herzig, K., Plaza‐Díaz, J., Franks, S., Morin-Papunen, L. C., Tapanainen, J. S., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa848 · Cited by 95
Khan, R., Jiang, X., Hameed, U., & Shi, Q. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.639704 · Cited by 92
The interplay between PCOS pathology and diet on gut microbiota in a mouse model
Paris, V. R., Wong, X. Y. D., Solon‐Biet, S. M., Edwards, M. C., Aflatounian, A., Gilchrist, R. B., Simpson, S. J., Handelsman, D. J., Kaakoush, N. O., & Walters, K. A. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2085961 · Cited by 92
“Several studies have reported altered microbial composition in PCOS rodent models17,18,20,23 and women with PCOS.13,14,24 One potential explanation for this shift is the presence of elevated levels of androgens, as a study in women with PCOS identified that β-diversity was negatively correlated with hyperandrogenism.1…”
BackgroundInfluentialChang, Z., Deng, G.-F., Shao, Y., Xu, D., Zhao, Y., Sun, Y.-F., Zhang, S.-Q., Hou, R., & Liu, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.670054 · Cited by 85
“Recently, accumulating researchers realized that the gut dysbacteriosis is inextricably linked to the onset of the chronic inflammatory diseases, especially PCOS (Insenser et al., 2018; Torres et al., 2018).”
BackgroundFox, C. W., Zhang, L., Sohni, A., Doblado, M., Wilkinson, M., Chang, R. J., & Dulęba, A. J. (2019) · Endocrinology · doi:10.1210/en.2019-00588 · Cited by 81
“women with PCOS include altered gut microbiota, resulting in increased intestinal permeability (48, 49)”
BackgroundCorrie, L., Awasthi, A., Kaur, J., Vishwas, S., Gulati, M., Kaur, I. P., Gupta, G., Kommineni, N., Dua, K., & Singh, S. K. (2023) · Pharmaceuticals · doi:10.3390/ph16020197 · Cited by 85
“The findings indicated that obese and non-obese women with PCOS had significantly different levels of β diversity [122].”
BackgroundPolycystic Ovary Syndrome: Challenges and Possible Solutions
Che, Y., Yu, J., Li, Y., Zhu, Y., & Tao, T. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041500 · Cited by 87
“Evidence showed that hyperandrogenism was negatively correlated to α diversity [21], while β diversity was reduced particularly in obese patients with PCOS [22].”
BackgroundHe, F., & Li, Y. (2021) · Journal of Ovarian Research · doi:10.1186/s13048-021-00799-9 · Cited by 81
Alterations in the intestinal microbiome associated with PCOS affect the clinical phenotype
Wang, L., Zhou, J., Gober, H.-J., Leung, W. T., Huang, Z., Pan, X., Li, C., Zhang, N., & Wang, L. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110958 · Cited by 87
Lee, C. J., Florea, L., Sears, C. L., Maruthur, N. M., Potter, J. J., Schweitzer, M., Magnuson, T. H., & Clark, J. M. (2019) · Obesity Surgery · doi:10.1007/s11695-019-03976-4 · Cited by 77
Gut microbiome in PCOS associates to serum metabolomics: a cross-sectional study
Yu, Z., Qin, E., Cheng, S., Yang, H., Liu, R., Xu, T., Liu, Y., Yuan, J., Yu, S., Yang, J., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-25041-4 · Cited by 80
Kelley, A. S., Smith, Y. R., & Padmanabhan, V. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00383 · Cited by 79
The role of the gut microbiome in sex differences in arterial pressure
Beale, A. L., Kaye, D. M., & Marques, F. Z. (2019) · Biology of Sex Differences · doi:10.1186/s13293-019-0236-8 · Cited by 78
Probiotics Dietary Supplementation for Modulating Endocrine and Fertility Microbiota Dysbiosis
López-Moreno, A., & Aguilera, M. (2020) · Nutrients · doi:10.3390/nu12030757 · Cited by 65
Dong, S., jiao, J., Jia, S., Li, G., Zhang, W., Yang, K., Wang, Z., Liu, C., Li, D., & Wang, X. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.634981 · Cited by 77
Arroyo, P., Ho, B., Sau, L., Kelley, S. T., & Thackray, V. G. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223274 · Cited by 76
Self-citationCozzolino, M., Vitagliano, A., Pellegrini, L., Chiurazzi, M., Andriasani, A., Ambrosini, G., & Garrido, N. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02233-0 · Cited by 75
Abnormal Endometrial Receptivity and Oxidative Stress in Polycystic Ovary Syndrome
Shan, H., Luo, R., Guo, X., Li, R., Ye, Z., Peng, T., Liu, F.-T., & Yang, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.904942 · Cited by 79
“In addition, compared with that in healthy controls, the abundance of common Bacteroides vulgatus in women with PCOS was significantly increased (Lindheim et al., 2017; Liu et al., 2017; Torres et al., 2018; Qi et al., 2019; Zeng et al., 2019).”
BackgroundInsulin Metabolism in Polycystic Ovary Syndrome: Secretion, Signaling, and Clearance
Herman, R., Sikonja, J., Jensterle, M., Janez, A., & Dolzan, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043140 · Cited by 69
Chu, W., Zhai, J., Xu, J., Li, S., Li, W., Chen, Z., & Du, Y. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.03145 · Cited by 73
Current and experimental drug therapy for the treatment of polycystic ovarian syndrome
Corte, L. D., Foreste, V., Barra, F., Gustavino, C., Alessandri, F., Centurioni, M. G., Ferrero, S., Bifulco, G., & Giampaolino, P. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1781815 · Cited by 71
Gut microbiota as the critical correlation of polycystic ovary syndrome and type 2 diabetes mellitus
Duan, L., An, X., Zhang, Y., Jin, D., Zhao, S., Zhou, R., Duan, Y., Zhang, Y., Liu, X., & Lian, F. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112094 · Cited by 70
Microbiota Alterations in Patients with Autoimmune Thyroid Diseases: A Systematic Review
Sawicka‐Gutaj, N., Gruszczyński, D., Zawalna, N., Nijakowski, K., Muller, I., Karpiński, T. M. M., Salvi, M., & Ruchała, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113450 · Cited by 72
Torres, P. J., Skarra, D. V., Ho, B., Sau, L., Anvar, A. R., Kelley, S. T., & Thackray, V. G. (2019) · BMC Microbiology · doi:10.1186/s12866-019-1425-7 · Cited by 70
Self-citationFu, C., Chen, Z., Chen, M., Chen, G., Huang, Q., Yang, X., Yin, H., Chen, L., Zhang, W., Lin, H., et al. (2021) · npj Biofilms and Microbiomes · doi:10.1038/s41522-021-00231-6 · Cited by 67
Yang, Y., Cheng, J., Liu, C., Zhang, X., Ma, N., Zhou, Z., Lu, W., & Wu, C. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102884 · Cited by 67
Elevation of markers of endotoxemia in women with polycystic ovary syndrome
Banaszewska, B., Siakowska, M., Chudzicka-Strugała, I., Chang, R. J., Pawelczyk, L. A., Zwoździak, B., Spaczyński, R., & Dulęba, A. J. (2020) · Human Reproduction · doi:10.1093/humrep/deaa194 · Cited by 66
Self-citationZheng, Y., Yu, J., Liang, C., Li, S., Wen, X., & Li, Y. (2020) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-020-02320-w · Cited by 64
Tan, S., Ge, W., Wang, J., Liu, W., Zhao, Y. M., Shen, W., & Li, L. (2019) · Chemosphere · doi:10.1016/j.chemosphere.2019.125493 · Cited by 63
Abbasi, A., Aghebati‐Maleki, A., Yousefi, M., & Maleki, L. A. (2020) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2020.103244 · Cited by 63
Li, T., Zhang, Y., Song, J., Chen, L., Du, ., & Mao, X. (2022) · Nutrients · doi:10.3390/nu14020279 · Cited by 63
“Compared with healthy women, the gut microbial diversity was reduced in PCOS patients with the change of relative abundance of specific Bacteroidetes and Firmicutes [7,8].”
BackgroundInfluentialComparative Analysis of Lower Genital Tract Microbiome Between PCOS and Healthy Women
Tu, Y., Zheng, G., Ding, G., Wu, Y., Xi, J., Ge, Y., Gu, H., Wang, Y., Sheng, J., Liu, X., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.01108 · Cited by 62
Characterization of gut microbiota in polycystic ovary syndrome: Findings from a lean population
Mammadova, G., Özkul, C., Işıkhan, S. Y., Açıkgöz, A., & Yıldız, B. O. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13417 · Cited by 66
Zhang, M., Hu, R., Huang, Y., Zhou, F., Li, F., Liu, Z., Geng, Y., Dong, H., Ma, W., Song, K., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.933110 · Cited by 66
“hormones, which are present in the liver (10, 11, 70).”
BackgroundClemente‐Suárez, V. J., Redondo-Flórez, L., Rubio-Zarapuz, A., Martín-Rodríguez, A., & Tornero-Aguilera, J. F. (2024) · Biomedicines · doi:10.3390/biomedicines12010221 · Cited by 64
“Moreover, as we consider the broader endocrine landscape, emerging studies like those by Torres et al. (2018) have explored the intriguing interplay between gut microbiota and sex hormones [337].”
BackgroundEyüpoğlu, D., Ergünay, K., Açıkgöz, A., Akyön, Y., Yılmaz, E., & Yıldız, B. O. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa600 · Cited by 66
Mukherjee, A. G., Wanjari, U. R., Kannampuzha, S., Murali, R., Namachivayam, A., Ganesan, R., Dey, A., Babu, A., Renu, K., Vellingiri, B., et al. (2023) · Metabolites · doi:10.3390/metabo13010129 · Cited by 66
“Even after controlling for BMI and age, they still detected a statistically significant increase in serum CRP among the study group [184–187].”
BackgroundResultInfluentialSex, puberty, and the gut microbiome
Sisk-Hackworth, L., Kelley, S. T., & Thackray, V. G. (2023) · Reproduction · doi:10.1530/rep-22-0303 · Cited by 61
“…I diabetes (T1D) (Markle et al. 2013, Yurkovetskiy et al. 2013), lupus (Young et al. 2014, He et al. 2016), obesity (Joriba et al. 2019), polycystic ovary syndrome (PCOS) (Torres et al. 2018, van Hooff et al. 1999, Jobira et al. 2020), and endometriosis (Yuan et al. 2018, Svensson et al. 2021).”
BackgroundInfluentialSelf-citationKaur, I., Suri, V., Sachdeva, N. K., Rana, S. V., Medhi, B., Sahni, N., Ahire, J. J., & Singh, A. (2022) · European Journal of Nutrition · doi:10.1007/s00394-022-02959-z · Cited by 60
“[19] showed that PCOS women had fewer types of gut microbes as compared to normal women, and this trend was related to an increase in androgens.”
BackgroundThe effects of microbiota on reproductive health: A review
Wang, N., Chen, L., Yi, K., Zhang, B., Li, C., & Zhou, X. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2117784 · Cited by 57
“Of note, androgen levels were also negatively correlated with the alpha diversity of gut microbiota (Torres et al. 2018).”
BackgroundWu, J., Wang, K., Qi, X., Zhou, S., Zhao, S., Lu, M., Nie, Q., Li, M., Han, M., Luo, X., et al. (2025) · Cell Host & Microbe · doi:10.1016/j.chom.2024.12.006 · Cited by 58
Eyüpoğlu, D., Guzelce, E. C., Açıkgöz, A., Uyanık, E., Bjørndal, B., Berge, R. K., Svardal, A. M., & Yıldız, B. O. (2019) · Clinical Endocrinology · doi:10.1111/cen.14101 · Cited by 51
Yang, Z., Fu, H., Su, H., Cai, X., Wang, Y., Hong, Y., Hu, J., Xie, Z., & Wang, X. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1017147 · Cited by 53
“According to previous reports, the diversity of gut microbiota is reduced in patients with PCOS; Several specific bacterial species including Bacteroidetes and Firmicutes are found to have an abnormal abundance in PCOS, and these changes in gut microbiota reveal strong correlations with PCOS manifestations encompassin…”
BackgroundHaudum, C., Lindheim, L., Ascani, A., Trummer, C., Horvath, A., Münzker, J., & Obermayer-Pietsch, B. (2020) · Nutrients · doi:10.3390/nu12061622 · Cited by 49
“Our baseline (T0) evaluations (Figure 4) confirm recent publications arguing a decreased gut microbial alpha diversity in PCOS women compared to healthy controls [2,108].”
BackgroundLin, W., Wen, L., Wen, J., & Xiang, G. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.747888 · Cited by 53
“Ruminococcus and Clostridium were shown to be enriched patients with PCOS (24) and rodent models of PCOS (25).”
BackgroundAcharya, A., Shetty, S. S., & Kumari, S. (2024) · Human Nutrition & Metabolism · doi:10.1016/j.hnm.2024.200256 · Cited by 49
Metadata
- Authors
- Torres, P. J., Siakowska, M., Banaszewska, B., Pawelczyk, L., Duleba, A. J., Kelley, S. T., & Thackray, V. G.
- Affiliations
- San Diego State University (US)
- Poznan University of Medical Sciences (PL)
- Department of Reproductive Medicine, University of California, San Diego, La Jolla, California
- University of California San Diego (US)
- Corresponding author
- Thackray, Varykina G
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2018-01-23
- Volume
- 103
- Issue
- 4
- Pages
- 1502-1511
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC6276580
- OpenAlex
- W2792000617
- Cited by
- 399
- References
- 42
- Citations by year
- 2026: 49 · 2025: 61 · 2024: 69 · 2023: 55 · 2022: 44 · 2021: 57 · 2020: 37 · 2019: 20 · 2018: 5
- FWCI
- 31.91
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD012303, R01HD082567)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- polycystic ovary syndrome, gut microbiota, hyperandrogenism, alpha diversity, beta diversity, polycystic ovary morphology, hirsutism, total testosterone, fecal microbiota, 16S rRNA gene sequencing, type 2 diabetes risk, metabolic disorders
- MeSH terms
- Gastrointestinal Microbiome, Adult, Feces, Female, Humans, Polycystic Ovary Syndrome, RNA, Ribosomal, 16S, Hyperandrogenism, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.